5‐LOX protein expression is also upregulated in Alzheimer's disease patients, and immunoreactivity induced using 5‐LOX amino terminus‐directed antibodies was lacking in neurons but abundant in neurofibrillary tangles, neuritic plaques, and glia.113. The gene discussed is ALOX5; the disease is early-onset autosomal dominant Alzheimer disease.